Follow on Google News News By Tag * Hemostasis Testing * Hemostasis Diagnostics * Hemostasis Diagnostics Market * Hemostasis Market Reports * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | Global Hemostasis Diagnostics Market: Global Outlook & OpportunitiesAnnouncing addition of a new seven-country, 650-page report designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the global hemostasis diagnostics market during this decade.
“Global Hemostasis Diagnostics Market: Global Outlook & Opportunities” “The Global Hemostasis Diagnostics Market” (http://www.vpgmarketresearch.com/ Rationale The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the hemostasis diagnostics practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Hemostasis testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the hemostasis testing closer to the patient, thus creating additional opportunities and challenges for suppliers. Geographic Coverage - France - Germany - Italy - Japan - Spain - UK - USA Sales and Market Share Analysis - Sales and market shares of major instrument and reagent suppliers. Competitive Assessments - Extensive strategic profiles of major suppliers and emerging market entrants. Market Segmentation Analysis - Comprehensive market segmentation analysis, including: - Hospitals - Commercial/Private Laboratories - Physician Offices - Ambulatory Care Clinics. - The 2010, 2015 and 2020 test forecasts for 40 major procedures, by country and market segment. Current and Emerging Products - Review of over 40 established and new procedures. - Comparison of over 50 automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex, Trinity Biotech and other suppliers. Technology Review - Analysis of current and emerging technologies and their potential market applicants. - Comprehensive lists of companies developing or marketing new technologies and products by test. Worldwide Market Overview - Estimates of facilities performing hemostasis diagnostic tests, by country. - Test volume and sales projections by country. Strategic Recommendations - Product development and business expansion opportunities with significant market appeal. - “Ideal” product models with tentative prices and operating characteristics. - Alternative market penetration strategies for instrument and reagent suppliers. - Potential market entry barriers and risks. Methodology The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, and Venture Planning Group’s proprietary data files was conducted. Contains 650 pages and 150 tables Table of Contents Introduction Worldwide Market and Technology Overview A. Major Routine and Special Hemostasis Tests 1. Introduction 2. Activated Partial Thromboplastin Time (APTT) 3. Alpha-2 Antiplasmin 4. Antithrombin III 5. Bleeding Time 6. D-Dimer 7. Ethanol Flocculation Test 8. Euglobulin Lysis 9. Factor Assays a. Introduction b. Factor II c. Factor V/Factor V Leiden d. Factor VII e. Factor VIII f. Factor IX g. Factor IXa h. Factor X (Stuart Factor) i. Factor Xa j. Factor XI k. Factor XII l. Factor XIII 10. Fibrin Degradation Products 11. Fibrinogen 12. Heparin 13. Hirudin 14. Hypercoagulability and Thrombosis 15. Lipoprotein a 16. Plasmin 17. Plasminogen 18. Plasminogen Activator Inhibitor (PAI) 19. Platelet Function Tests 20. Platelet Aggregation 21. Proteins C and S 22. Prothrombin Fragment 1.2 23. Prothrombin Time (PT) 24. Reptilase Time 25. Thrombin Time 26. Tissue-Type Plasminogen Activator (t-PA) 27. Von Willebrand's Factor B. Instrumentation Review - Introduction - Benk Hemolab - Benk TRT Thrombotimer - Bio/Data MCA 310 - Bio/Data MCA 210 - Bio/Data PAP-4C D/4D/4C - Cardiovascular Diagnostics COAG - Diagnostica Stago STA Compact - Diagnostica Stago STA-R - Diagnostica Stago Star 4/8 - Helena Laboratories Cascade 480 - Helena Laboratories Cascade M - Helena Laboratories PACKS-4 - Helena THOR - Instrumentation Laboratory ACL 100 and 1000 series - Instrumentation Laboratory ACL6000 - Instrumentation Laboratory ACL7000 - Instrumentation Laboratory ACL9000 - Instrumentation Laboratory Electra 1000C - Instrumentation Laboratory Electra 1400C - Instrumentation Laboratory Electra 1600/C - Instrumentation Laboratory Electra 1800C - Instrumentation Laboratory Futura - ITC Hemochron 8000 - Roche Diagnostics CoaguChek - Siemens BCS - Siemens BCT - Siemens BF II/Fibrintimer Series - Sysmex CA-50 - Sysmex CA-500 - Sysmex CA-1500 - Sysmex CA-5000/CA-1000 - Sysmex CA-6000 - Sysmex CA-7000 - Teco Coatron II/Jr./AccuStasis 5000 - Trinity Biotech Amax CS190 - Trinity Biotech Amax CS400 - Trinity Biotech Coag-A-Mate Max - Trinity Biotech KC 40, 4A, 1A Series - Trinity Biotech MDA 180 - Trinity Biotech Coag-A-Mate MTX - Trinity Biotech Coag-A-Mate RA4 - Trinity Biotech Coag-A-Mate XC/Plus - Trinity Biotech Coag-A-Mate XM C. Major in Vitro Diagnostic Technologies and Their Potential Applications 1. Chromogenic Substrates 2. Monoclonal and Polyclonal Antibodies 3. Immunoassays 4. Microcomputers 5. Automation 6. Robotics 7. DNA Probes 8. Artificial Intelligence 9. Dry Chemistry 10. Biosensors D. Worldwide Market Overview France Germany Italy Japan Spain UK USA Major Product Development Opportunities Design Criteria For Decentralized Testing Products Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies for Decentralized Testing Markets 1. Marketing Approaches 2. Product Complexity 3. Customer Preference 4. Established Suppliers 5. Emerging Suppliers 6. Major Types Of Distributors 7. Market Segmentation Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges Competitive Assessments - Abbott - American Diagnostica - Avocet Medical - Axis-Shield - Beckman Coulter - Becton Dickinson - Bio/Data Corporation - Biosite - Chrono-Log - Corgenix Medical - Diagnostica Stago - Helena Laboratories - HYPEN BioMed - Instrumentation Laboratory - ITC - Nanogen - Roche - Siemens - Sienco - Sysmex - Thermo Fischer - Trinity Biotech - ZyCare Best regards, Robert Fisher Healthcare Research robert@vpgcorp.com +1 212 564 2838 http://www.VPGMarketResearch.com # # # Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the Diagnostics, Pharmaceutical, Imaging, Orthopedics, Biotechnology, Chemical, Flavors & Fragrances, Food & Beverage, Electronics, and other industries. During numerous proprietary single-client consulting assignments and over 500 multiclient studies, VPG has developed an extensive database on various industries, technologies, markets, companies, products, and executives worldwide. VPG has served over 1,000 corporations in 70 countries, and has established a broad network of worldwide contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government. Specialties Market Intelligence Surveys, Opportunity Analyses, New Technology/Product Assessments, Acquisition/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|